Bard Associates Inc. lessened its holdings in shares of Balchem Corporation (NASDAQ:BCPC) by 1.5% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 44,738 shares of the basic materials company’s stock after selling 700 shares during the period. Balchem Corporation accounts for about 1.6% of Bard Associates Inc.’s investment portfolio, making the stock its 11th biggest holding. Bard Associates Inc. owned 0.14% of Balchem Corporation worth $3,477,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also added to or reduced their stakes in the company. Bessemer Group Inc. raised its holdings in shares of Balchem Corporation by 0.6% during the second quarter. Bessemer Group Inc. now owns 17,300 shares of the basic materials company’s stock valued at $1,344,000 after buying an additional 100 shares during the last quarter. Oppenheimer Asset Management Inc. raised its holdings in shares of Balchem Corporation by 2.4% during the second quarter. Oppenheimer Asset Management Inc. now owns 5,133 shares of the basic materials company’s stock valued at $400,000 after buying an additional 118 shares during the last quarter. Texas Permanent School Fund raised its holdings in shares of Balchem Corporation by 1.1% during the second quarter. Texas Permanent School Fund now owns 23,266 shares of the basic materials company’s stock valued at $1,808,000 after buying an additional 263 shares during the last quarter. Municipal Employees Retirement System of Michigan raised its holdings in shares of Balchem Corporation by 4.0% during the second quarter. Municipal Employees Retirement System of Michigan now owns 7,500 shares of the basic materials company’s stock valued at $583,000 after buying an additional 290 shares during the last quarter. Finally, Victory Capital Management Inc. raised its holdings in shares of Balchem Corporation by 17.6% during the second quarter. Victory Capital Management Inc. now owns 2,130 shares of the basic materials company’s stock valued at $166,000 after buying an additional 319 shares during the last quarter. 84.22% of the stock is currently owned by institutional investors.
Separately, BidaskClub cut Balchem Corporation from a “sell” rating to a “strong sell” rating in a report on Monday, July 31st.
In other news, Director Edward Mcmillan sold 2,557 shares of the stock in a transaction that occurred on Thursday, June 15th. The shares were sold at an average price of $81.09, for a total transaction of $207,347.13. Following the sale, the director now directly owns 25,739 shares of the company’s stock, valued at $2,087,175.51. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 1.59% of the stock is owned by corporate insiders.
Shares of Balchem Corporation (BCPC) traded up 0.08% during midday trading on Friday, reaching $74.83. The company had a trading volume of 116,567 shares. The firm’s 50 day moving average price is $75.57 and its 200-day moving average price is $79.46. The company has a market capitalization of $2.39 billion, a P/E ratio of 38.77 and a beta of 1.10. Balchem Corporation has a 12 month low of $65.37 and a 12 month high of $89.50.
Balchem Corporation (NASDAQ:BCPC) last released its quarterly earnings results on Friday, August 4th. The basic materials company reported $0.64 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.63 by $0.01. Balchem Corporation had a net margin of 10.99% and a return on equity of 14.99%. The business had revenue of $147.08 million for the quarter. Analysts anticipate that Balchem Corporation will post $2.48 earnings per share for the current fiscal year.
WARNING: This article was originally published by Sports Perspectives and is owned by of Sports Perspectives. If you are reading this article on another publication, it was copied illegally and reposted in violation of United States & international copyright and trademark legislation. The legal version of this article can be viewed at https://sportsperspectives.com/2017/09/10/balchem-corporation-bcpc-stake-decreased-by-bard-associates-inc.html.
Balchem Corporation Profile
Balchem Corporation is engaged in the development, manufacture and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization and industrial markets. The Company operates in four segments: Human Nutrition & Health, Animal Nutrition & Health, Specialty Products and Industrial Products.
Receive News & Ratings for Balchem Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem Corporation and related companies with MarketBeat.com's FREE daily email newsletter.